GGrantIndex
← Search

Developmental Funds

$446,768P30FY2013CANIH

University Of Wisconsin-Madison, Madison WI

Investigators

Linked publications, trials & patents

Paper 39638850Paper 39604703Paper 39580301Paper 39530524Paper 39527745Paper 39516197Paper 39484544Paper 39481346Paper 39474803Paper 39462136Paper 39452931Paper 39444276Paper 39443360Paper 39432401Paper 39414902Paper 39408582Paper 39407431Paper 39402986Paper 39399121Paper 39386576Paper 39386545Paper 39379374Paper 39374311Paper 39364328Paper 39358429Paper 39345631Paper 39335130Paper 39312186Trial NCT06608511Trial NCT06557733Trial NCT05985681Trial NCT05521698Trial NCT05107219Trial NCT03725761Trial NCT03722030Trial NCT03703492Trial NCT03656276Trial NCT03393741Trial NCT03387514Trial NCT03358563Trial NCT03356470Trial NCT03342378Trial NCT03304002Trial NCT03300557Trial NCT03209869Trial NCT03185871Trial NCT03028584Trial NCT03023202Trial NCT02955043Trial NCT02917629Trial NCT02876640Trial NCT02780401Trial NCT02719821Trial NCT02169284Trial NCT02096783Trial NCT02095145Trial NCT01999881Trial NCT01935960Trial NCT01901835Trial NCT01707004Trial NCT01625156Trial NCT01325311Trial NCT01263613Trial NCT01245205Trial NCT01243359Trial NCT01233505Trial NCT01218620Trial NCT01217450Trial NCT01158274Trial NCT01083641Trial NCT01004796Trial NCT00896974Trial NCT00666562Trial NCT00544596Trial NCT00499135Trial NCT00462969Trial NCT00415025Trial NCT00410605Trial NCT00227513Trial NCT00138203Trial NCT00109863Trial NCT00079014Trial NCT00052832Trial NCT00049712Trial NCT00036790Trial NCT00028652Trial NCT00023855Trial NCT00022412Trial NCT00005794Trial NCT00004872Patent 9867974Patent 9763597Patent 9603567Patent 9470697Patent 9161720Patent 8871458Patent 6974254Patent 6438202Patent 6114119Patent 6020178

Abstract

The flexibility of CCSG Development funds provides the Director with the ability to support evolving opportunities that support the goals established by the leaders of UWCCC. There are three areas where Development Funds play a critical role: start-up support for new faculty; pilot project research funding and the development of new Shared Resources. The Director commits CCSG development funds for start-up support for faculty candidates who provide the most promising opportunities for significant contributions to the Scientific Programs of UWCCC. During the current grant period, UWCCC contributed $2.5 million towards the recruitment of 28 tenure track faculty. These faculty have been awarded approximately $43.4 million in grant funding for a 17 fold return on investment to date. In concert with the priorities established for future development, candidates will be chosen because of their promising potential to conduct laboratory cancer research leading to translation, or to contribute to applied research resulting from translation. Pilot projects are an important mechanism to support early explorations leading to research that will fulfill the discovery through translation mission of UWCCC. A coordinated process, similar to an NIH study section, ensures that the resources of UWCCC are used effectively. The process has evolved to align the goal of strengthening cancer-focused collaborative projects that include intra- and trans-disciplinary laboratory and clinical research with translational end-points. During the current grant period. UWCCC funded 85 pilots with $4 million which have generated approximately $23 million in grant awards and 66 publications to date. Shared Resources are one of the most important mechanisms that UWCCC uses to encourage investigators to take advantage of opportunities for collaboration and focus their research on cancer. Scientific opportunity is a powerful enticement, but when it is paired with fiscal benefit, the opportunity is magnified. We will allocate resources for new Shared Resources that will have a significant impact on the translational potential of our research efforts and support areas targeted for future development. Future Shared Resource development in the next grant period will focus on informatics and genomics.

View original record on NIH RePORTER →